August 12, 2025Neuro-Oncology AdvancesOpen Access

Rdta-08 Multi-Sequential Stereotactic Radiosurgery (Srs) for Brain Metastases: 10-Year Experience From the Chuv (Lausanne, Switzerland) Brain Metastasis Clinic

View Full Paper

Ask AI

Bookmark

Multi-sequential SRS achieved a median overall survival of 32 months in patients with brain metastases, confirming its effectiveness.
The cohort involved 223 patients receiving a median of 4 SRS courses, with a high local control rate of 97% at one year.
Analysis of the BRAINMETS cohort provided insights into treatment patterns and outcomes, emphasizing SRS's role in brain metastases management.
The findings suggest that dedicated brain metastasis clinics are crucial for integrating precision therapy and improving survival outcomes.

Discussion

No takes yet. Share an insight, caveat, or question.

Observational analysis shows prolonged survival and high local control in patients with brain metastases, indicating SRS may reduce WBRT necessity.

Sychold et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Observational analysis shows prolonged survival and high local control in patients with brain metastases, indicating SRS may reduce WBRT necessity.